1,077 filings
Page 29 of 54
10-Q
2018 Q1
EYPT
EyePoint Pharmaceuticals, Inc.
Quarterly report
8 Nov 17
12:00am
8-K
EYPT
EyePoint Pharmaceuticals, Inc.
7 Nov 17
Results of Operations and Financial Condition
12:00am
PRE 14A
EYPT
EyePoint Pharmaceuticals, Inc.
Preliminary proxy
3 Nov 17
12:00am
CT ORDER
EYPT
EyePoint Pharmaceuticals, Inc.
2 Oct 17
Confidential treatment order
12:00am
424B5
EYPT
EyePoint Pharmaceuticals, Inc.
20 Sep 17
Prospectus supplement for primary offering
12:00am
10-K
2017 FY
EYPT
EyePoint Pharmaceuticals, Inc.
Annual report
13 Sep 17
12:00am
8-K
EYPT
EyePoint Pharmaceuticals, Inc.
11 Sep 17
Results of Operations and Financial Condition
12:00am
8-K
EYPT
EyePoint Pharmaceuticals, Inc.
10 Jul 17
Entry into a Material Definitive Agreement
12:00am
3
Kristine Peterson
30 Jun 17
pSivida / Kristine Peterson ownership change
12:00am
8-K
EYPT
EyePoint Pharmaceuticals, Inc.
30 Jun 17
Departure of Directors or Certain Officers
12:00am
4
Debora Jorn
29 Jun 17
pSivida / DEBORA JORN ownership change
12:00am
4
Dario A. Paggiarino
29 Jun 17
pSivida / Dario A. Paggiarino ownership change
12:00am
8-K
EYPT
EyePoint Pharmaceuticals, Inc.
29 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
4
Leonard S Ross
29 Jun 17
pSivida / Leonard S Ross ownership change
12:00am
8-K
EYPT
EyePoint Pharmaceuticals, Inc.
22 Jun 17
Approval of Durasertâ„¢ Three-year Treatment for Posterior Segment
12:00am
4
Nancy Lurker
14 Jun 17
pSivida / Nancy Lurker ownership change
12:00am
8-K
EYPT
EyePoint Pharmaceuticals, Inc.
13 Jun 17
Successfully Achieves Primary Efficacy Endpoint in Second Phase 3 Study
12:00am
SC 13D/A
PFE
Pfizer Inc.
26 May 17
pSivida Corp.
12:00am
DEF 14A
EYPT
EyePoint Pharmaceuticals, Inc.
Definitive proxy
15 May 17
12:00am